GovWire

Guidance: COVID-19: PHE laboratory assessments of molecular tests

Public Health England

June 4
08:00 2020

Rapid assessment of selected commercial molecular diagnostic tests for the laboratory detection of COVID-19 infections

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email publications@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: ViaSure SARS-CoV-2 Real Time PCR detection Kit

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email publications@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Seegene Allplex 2019-nCoV assay for the detection of SARS-CoV-2 (COVID-19)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email publications@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Roche Ltd Coronavirus LightMix Modular SARS and Wuhan CoV E-gene assay

This file may not be suitable for users of assistive technology.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: